Related Experiment Video
Updated: Oct 2, 2025

05:49
Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders
Published on: November 1, 2024
989
An Outperforming Artificial Intelligence Model to Identify Referable Blepharoptosis for General Practitioners
Ju-Yi Hung1,2, Ke-Wei Chen1,3, Chandrashan Perera1
1Ophthalmology, Byers Eye Institute, Stanford University School of Medicine, 2452 Watson Court, Palo Alto, CA 94303, USA.
Journal of Personalized Medicine
|February 25, 2022
Summary
An AI model accurately identifies blepharoptosis (droopy eyelid) with higher accuracy than non-ophthalmic physicians. This AI tool shows potential for aiding general practitioners in diagnosing and referring patients with this condition.
Area of Science:
- Ophthalmology
- Artificial Intelligence
- Medical Imaging
Background:
- Blepharoptosis, or a droopy eyelid, requires accurate identification for timely referral and treatment.
- Current diagnostic methods may be limited in accuracy among non-specialists.
- There is a need for objective tools to aid in the diagnosis of blepharoptosis.
Purpose of the Study:
- To develop and evaluate an AI model for automatic detection of referable blepharoptosis.
- To compare the diagnostic performance of the AI model against non-ophthalmic physicians.
Main Methods:
- A convolutional neural network (CNN) was trained on 1000 retrospective eye images labeled by oculoplastic surgeons.
- The AI model performed binary classification to identify blepharoptosis (true and pseudoptosis) or a healthy eyelid.
- The same dataset was used to test the performance of three non-ophthalmic physicians.
Main Results:
- The CNN model achieved 92% sensitivity and 88% specificity.
- Non-ophthalmic physicians achieved a mean sensitivity of 72% and a mean specificity of 82.67%.
- The AI model demonstrated superior performance in identifying referable blepharoptosis compared to the physician group.
Conclusions:
- AI-powered tools can accurately identify blepharoptosis, outperforming non-specialist physicians.
- Artificial intelligence holds significant potential to assist general practitioners in diagnosing and referring blepharoptosis cases.
- AI can improve the efficiency and accuracy of blepharoptosis screening in primary care settings.

